Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Medtronic initiates U.S. clinical trials of beStent Rival

Aug. 25, 1997

Xoma discloses rBPI-Ig fusion proteins

Aug. 25, 1997

PDGFr tyrosine kinase inhibitor with potential in atherosclerosis

Aug. 25, 1997

Merck KGaA begins development of cardioprotectant

Aug. 20, 1997

Viazem approved in 10 European countries

Aug. 20, 1997

Preclinical results on AVI-2221 for restenosis

Aug. 19, 1997

Generic Cardizem CD open for FDA review

Aug. 19, 1997

CardioSynopsis, IHIM to co-develop novel stents

Aug. 19, 1997

New biotech company formed to combat cardiovascular diseases

Aug. 18, 1997

NIH research grant goes to Diatide for arterial thrombosis therapy

Aug. 14, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 14, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...